Biotechnology has helped transform what is possible in medicine, turning once-fatal diseases into manageable conditions and opening the door to treatments that would have seemed impossible a generation ago. But as science advances, the systems that support innovation are under pressure, from public trust and policy decisions to capital formation, regulation, and confidence in scientific institutions.

In this episode of Russo Edge, Dr. Jeremy Levin, co-founder and executive chairman of Ovid Therapeutics, former CEO of Teva, former chair of BIO, and a longtime biopharma leader whose career has included senior roles at Bristol Myers Squibb and Novartis, joins host Solomon Wilcots for a conversation on why biotech should be viewed as one of America’s most important strategic assets.

The conversation also explores the difference between biotech innovators and larger pharmaceutical companies, the complexity of drug pricing, the role of middlemen in the healthcare system, and why the public often does not see the full story behind how medicines are discovered, developed, funded, and delivered.

Whether you are a biotech leader, investor, policymaker, or simply interested in the future of medicine, this episode offers a timely look at the pressures facing the industry and the choices that will shape what comes next.

What if the systems that keep people alive, healthy, and productive were valued the same way elite organizations value performance?

In this episode, Solomon Wilcots speaks with Dr. Michelle Williams, professor of epidemiology and population health at Stanford University School of Medicine, former dean of the Harvard T.H. Chan School of Public Health, and author of The Cure for Everything. She explains how the often-invisible systems of public health shape daily life, from clean air and safe water to maternal health and prevention, and why public health should be seen not only as a moral imperative, but as an economic one.

This conversation examines what happens when public health systems are built well, when they are neglected, and why prevention should be understood not as an afterthought, but as an investment in resilience and long-term prosperity.

What’s really putting pressure on hospitals today, and what does it mean for the companies working with them?

In this episode of the Russo Edge, Scott Becker, founder and publisher of Becker’s Healthcare, joins host Solomon Wilcots to explore the new realities shaping hospitals and health systems across the country. Drawing from daily conversations with executives on the front lines, Scott offers a clear view of how they are navigating a more complex, resource-constrained environment while continuing to deliver patient care at scale.

If you lead a healthcare organization, build solutions for hospitals, or want a sharper understanding of how the system is evolving, this conversation offers a grounded, executive-level perspective on what matters now and what to watch next.